313 related articles for article (PubMed ID: 35346300)
1. Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.
Granata V; Fusco R; Belli A; Borzillo V; Palumbo P; Bruno F; Grassi R; Ottaiano A; Nasti G; Pilone V; Petrillo A; Izzo F
Infect Agent Cancer; 2022 Mar; 17(1):13. PubMed ID: 35346300
[TBL] [Abstract][Full Text] [Related]
2. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis.
Xue B; Wu S; Zhang M; Hong J; Liu B; Xu N; Zeng Q; Tang K; Zheng X
Abdom Radiol (NY); 2021 Aug; 46(8):3835-3844. PubMed ID: 33728532
[TBL] [Abstract][Full Text] [Related]
3. Differentiation combined hepatocellular and cholangiocarcinoma from intrahepatic cholangiocarcinoma based on radiomics machine learning.
Zhang J; Huang Z; Cao L; Zhang Z; Wei Y; Zhang X; Song B
Ann Transl Med; 2020 Feb; 8(4):119. PubMed ID: 32175412
[TBL] [Abstract][Full Text] [Related]
4. Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma.
Brunese MC; Fantozzi MR; Fusco R; De Muzio F; Gabelloni M; Danti G; Borgheresi A; Palumbo P; Bruno F; Gandolfo N; Giovagnoni A; Miele V; Barile A; Granata V
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189589
[TBL] [Abstract][Full Text] [Related]
5. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Ultrasound Radiomics Signatures for Noninvasive Evaluation of Biological Characteristics of Intrahepatic Cholangiocarcinoma.
Peng YT; Zhou CY; Lin P; Wen DY; Wang XD; Zhong XZ; Pan DH; Que Q; Li X; Chen L; He Y; Yang H
Acad Radiol; 2020 Jun; 27(6):785-797. PubMed ID: 31494003
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
8. A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy.
Deng L; Chen B; Zhan C; Yu H; Zheng J; Bao W; Deng T; Zheng C; Wu L; Yang Y; Yu Z; Wang Y; Chen G
Front Oncol; 2021; 11():744311. PubMed ID: 34868941
[TBL] [Abstract][Full Text] [Related]
9. Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma.
Liang W; Xu L; Yang P; Zhang L; Wan D; Huang Q; Niu T; Chen F
Front Oncol; 2018; 8():360. PubMed ID: 30234019
[No Abstract] [Full Text] [Related]
10. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
Seo N; Kim DY; Choi JY
AJR Am J Roentgenol; 2017 Aug; 209(2):W64-W75. PubMed ID: 28570102
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Analysis of Contrast-Enhanced CT for the Preoperative Prediction of Microvascular Invasion in Mass-Forming Intrahepatic Cholangiocarcinoma.
Xiang F; Wei S; Liu X; Liang X; Yang L; Yan S
Front Oncol; 2021; 11():774117. PubMed ID: 34869018
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Based Radiomics Analysis for Preoperatively Predicting Different Histopathological Subtypes of Primary Liver Cancer.
Peng Y; Lin P; Wu L; Wan D; Zhao Y; Liang L; Ma X; Qin H; Liu Y; Li X; Wang X; He Y; Yang H
Front Oncol; 2020; 10():1646. PubMed ID: 33072550
[TBL] [Abstract][Full Text] [Related]
14. A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma.
Qian X; Lu X; Ma X; Zhang Y; Zhou C; Wang F; Shi Y; Zeng M
Front Oncol; 2022; 12():838701. PubMed ID: 35280821
[TBL] [Abstract][Full Text] [Related]
15. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
[TBL] [Abstract][Full Text] [Related]
16. A Radiomics-based Approach for Predicting Early Recurrence in Intrahepatic Cholangiocarcinoma after Surgical Resection: A Multicenter Study.
Hao X; Liu B; Hu X; Wei J; Han Y; Liu X; Chen Z; Li J; Bai J; Chen Y; Wang J; Niu M; Tian J
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():3659-3662. PubMed ID: 34892030
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative Imaging Characteristics in Histology-Proven Resected Intrahepatic Cholangiocarcinoma.
Cheng N; Khoo N; Chung AYF; Goh BKP; Cheow PC; Chow PKH; Lee SY; Ooi LL; Jeyaraj PR; Kam JH; Koh YX; Chan CY; Teo JY
World J Surg; 2020 Nov; 44(11):3862-3867. PubMed ID: 32720003
[TBL] [Abstract][Full Text] [Related]
18. Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
Chi Z; Bhalla A; Saeed O; Cheng L; Curless K; Wang HL; Patil DT; Lin J
Hum Pathol; 2018 Aug; 78():131-137. PubMed ID: 29698701
[TBL] [Abstract][Full Text] [Related]
19. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
Galassi M; Iavarone M; Rossi S; Bota S; Vavassori S; Rosa L; Leoni S; Venerandi L; Marinelli S; Sangiovanni A; Veronese L; Fraquelli M; Granito A; Golfieri R; Colombo M; Bolondi L; Piscaglia F
Liver Int; 2013 May; 33(5):771-9. PubMed ID: 23445369
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
